Literature DB >> 12220029

Four fraction palliative radiotherapy for osteosarcoma in 24 dogs.

Eric M Green1, William M Adams, Lisa J Forrest.   

Abstract

Twenty-four dogs underwent palliative radiotherapy consisting of four 8 gray (Gy) fractions of 60Co radiation on days 0, 7, 14, and 21 at 26 sites for axial (n=11) or appendicular (n=15) osteosarcoma. Response was noted in 92% of sites treated. Seventeen dogs were euthanized due to local or metastatic disease, one dog died of metastatic disease, five dogs died of unrelated causes, and one dog is alive. The four fraction protocol is effective for palliation of clinical signs associated with axial or appendicular osteosarcoma and may result in a higher response rate and longer survival time than three fraction palliative protocols.

Entities:  

Mesh:

Year:  2002        PMID: 12220029     DOI: 10.5326/0380445

Source DB:  PubMed          Journal:  J Am Anim Hosp Assoc        ISSN: 0587-2871            Impact factor:   1.023


  11 in total

Review 1.  Palliative radiation therapy for canine osteosarcoma.

Authors:  Monique N Mayer; Candace K Grier
Journal:  Can Vet J       Date:  2006-07       Impact factor: 1.008

2.  Evaluation of outcome and prognostic factors for dogs living greater than one year after diagnosis of osteosarcoma: 90 cases (1997-2008).

Authors:  William T N Culp; Francisco Olea-Popelka; Jennifer Sefton; Charles F Aldridge; Stephen J Withrow; Mary H Lafferty; Robert B Rebhun; Michael S Kent; Nicole Ehrhart
Journal:  J Am Vet Med Assoc       Date:  2014-11-15       Impact factor: 1.936

3.  Retrospective Evaluation of Outcome in Dogs With Appendicular Osteosarcoma Following Hypofractionated Palliative Radiation Therapy With or Without Bisphosphonates: 165 Cases (2010-2019).

Authors:  Beck Ringdahl-Mayland; Douglas H Thamm; Tiffany W Martin
Journal:  Front Vet Sci       Date:  2022-05-10

4.  Relative biological effectiveness in canine osteosarcoma cells irradiated with accelerated charged particles.

Authors:  Junko Maeda; Ian M Cartwright; Jeremy S Haskins; Yoshihiro Fujii; Hiroshi Fujisawa; Hirokazu Hirakawa; Mitsuru Uesaka; Hisashi Kitamura; Akira Fujimori; Douglas H Thamm; Takamitsu A Kato
Journal:  Oncol Lett       Date:  2016-06-30       Impact factor: 2.967

Review 5.  Canine sarcomas as a surrogate for the human disease.

Authors:  Daniel L Gustafson; Dawn L Duval; Daniel P Regan; Douglas H Thamm
Journal:  Pharmacol Ther       Date:  2018-03-09       Impact factor: 12.310

6.  Metronomic administration of lomustine following palliative radiation therapy for appendicular osteosarcoma in dogs.

Authors:  Megan E Duffy; Christie L Anderson; Kevin Choy; Janean L Fidel
Journal:  Can Vet J       Date:  2018-02       Impact factor: 1.008

7.  Outcome and prognosis for canine appendicular osteosarcoma treated with stereotactic body radiation therapy in 123 dogs.

Authors:  Tiffany Wormhoudt Martin; Lynn Griffin; James Custis; Stewart D Ryan; Mary Lafferty; Mary-Keara Boss; Daniel Regan; Sangeeta Rao; Del Leary; Stephen J Withrow; Susan M LaRue
Journal:  Vet Comp Oncol       Date:  2021-01-13       Impact factor: 2.385

8.  Radiotherapy enhances natural killer cell cytotoxicity and localization in pre-clinical canine sarcomas and first-in-dog clinical trial.

Authors:  Robert J Canter; Steven K Grossenbacher; Jennifer A Foltz; Ian R Sturgill; Jiwon S Park; Jesus I Luna; Michael S Kent; William T N Culp; Mingyi Chen; Jaime F Modiano; Arta M Monjazeb; Dean A Lee; William J Murphy
Journal:  J Immunother Cancer       Date:  2017-12-19       Impact factor: 13.751

9.  Combination Therapy with Zoledronic Acid and Parathyroid Hormone Improves Bone Architecture and Strength following a Clinically-Relevant Dose of Stereotactic Radiation Therapy for the Local Treatment of Canine Osteosarcoma in Athymic Rats.

Authors:  Ryan C Curtis; James T Custis; Nicole P Ehrhart; E J Ehrhart; Keith W Condon; Sara E Gookin; Seth W Donahue
Journal:  PLoS One       Date:  2016-06-22       Impact factor: 3.240

10.  Axial Multicentric Osteosarcoma in an English Cocker Spaniel.

Authors:  B Parzefall; S De Decker; S Carvalho; R Terry; J Leach; K C Smith; A Lara-Garcia
Journal:  J Vet Intern Med       Date:  2016-08-13       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.